Simi Sistani, WW International CEO, talks Ozempic, technology and the company's new approach to weight loss. She speaks with Bloomberg's Caroline Hyde

Simi Sistani, WW International CEO, talks Ozempic, technology and the company's new approach to weight loss. She speaks with Bloomberg's Caroline Hyde

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics and entertainment.

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics and entertainment.

Listen to top interviews from Bloomberg News.

Bloomberg Talks

Sima Sistani Talks New Approaches in Weight Loss

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/d0b9f1b8-c676-4658-9e80-b04401379e51/transcript

Delta CEO Ed Bastian say the airline is seeing double-digit growth in business travel and they are focused on growing internationally. He speaks to Bloomberg's  Lisa Abramowicz

Delta CEO Ed Bastian say the airline is seeing double-digit growth in business travel and they are focused on growing internationally. He speaks to Bloomberg's&nbsp; Lisa Abramowicz

Delta CEO Ed Bastian Talks Premium Travel

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/0df15c29-1b6b-4714-b41c-b3d20101d92d/transcript

Eric Rosengren, former Boston Fed President, says administration actions could weaken confidence in Fed independence and complicate rate cuts. He tells Romaine Bostick on “The Close” that even if short-term rates fall, long-term rates may rise as markets fear persistent inflation.

Eric Rosengren, former Boston Fed President, says administration actions could weaken confidence in Fed independence and complicate rate cuts. He tells Romaine Bostick on &ldquo;The Close&rdquo; that even if short-term rates fall, long-term rates may rise as markets fear persistent inflation.

Eric Rosengren Talks Fed

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/9c8d484e-e451-4eda-8225-b3d10170b712/transcript

Novo Nordisk CEO Mike Doustdar talks about launching a pill version of their blockbuster obesity drug Wegovy in the US. He speaks to Katie Greifeld in San Francisco at the annual JPMorgan Healthcare Conference. 

Novo Nordisk CEO Mike Doustdar talks about launching a pill version of their blockbuster obesity drug Wegovy in the US. He speaks to Katie Greifeld in San Francisco at the annual JPMorgan Healthcare Conference.&nbsp;

Mike Doustdar Talks Strong Demand for Weight Loss Pills

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/b653fc15-c4aa-4547-a7b7-b3d1016f9887/transcript

Sima Sistani Talks New Approaches in Weight Loss

In 1 playlist(s)

Bloomberg Talks

Social links

Follow podcast

Recent clips